HEPATIQ® is The Ultimate Liver Test™ as it provides six indices of liver disease from a single scan including quantitative liver function.
HEPATIQ® is The Ultimate Liver Test™ as it provides six indices of liver disease from a single scan: quantitative liver function, fatty liver disease/steatohepatitis, portal hypertension, alcoholic hepatitis, fibrosis stage and variceal size.[1-23]
Not only does HEPATIQ provide six indices from a single test, it is the only product on the market that precisely and non-invasively quantifies liver function. Other techniques such as biopsies, elastography and blood tests estimate or score liver fibrosis but do not quantify function.
Quantitative liver function (PHM) can be reduced by infections, alcohol and fat buildup that cause the accumulation of fibrosis or scar tissue. The liver can regenerate new functioning nodules, and blood flow to the liver may increase, providing some mitigation.
A large, badly scarred, stiff liver can have normal function (PHM>100)  if there are enough functional nodules. Once a patient’s PHM drops below 75, they may decompensate, that is, develop clinical problems. [5,6,9,12,17,18,22]
If their PHM falls below 60, they may die if not transplanted soon. [8,13,16] If patients are treated and chronic liver injury is controlled, their PHM may improve.
Brands: Biopsies, elastography and blood tests estimate or score liver fibrosis. Patient outcomes are determined by residual liver function, not the extent of fibrosis. This was established in the 8 year HALT-C trial, which concluded that quantitative liver function may be more accurate than staging fibrosis in predicting clinical outcomes.[5,6] Subsequent clinical research has further confirmed that function outperforms fibrosis in predicting outcomes. [10,11,14,15,19,20,22]
We are offering new customers a six month trial of up to 50 HEPATIQ physician reports at no cost. Let your clinical physicians know you have this capability so they will refer their liver disease patients for a liver SPECT scan (CPT 78803) which is covered by most insurance (Medicare pays approximately US$1,400). You then use the cloud HEPATIQ software to process these images and produce the HEPATIQ report for distribution to the referring physician.
HEPATIQ can dramatically boost radiology revenues. HEPATIQ is the only test that quantifies liver function. All of the other tests on the market (blood, elastography and biopsy) estimate the extent of liver fibrosis. Research shows that function outperforms fibrosis in the prediction of disease outcomes. The HEPATIQ software is cleared for sale by the FDA.